Page last updated: 2024-11-01

nimodipine and Breast Neoplasms

nimodipine has been researched along with Breast Neoplasms in 3 studies

Nimodipine: A calcium channel blockader with preferential cerebrovascular activity. It has marked cerebrovascular dilating effects and lowers blood pressure.
nimodipine : A dihydropyridine that is 1,4-dihydropyridine which is substituted by methyl groups at positions 2 and 6, a (2-methoxyethoxy)carbonyl group at position 3, a m-nitrophenyl group at position 4, and an isopropoxycarbonyl group at position 5. An L-type calcium channel blocker, it acts particularly on cerebral circulation, and is used both orally and intravenously for the prevention and treatment of subarachnoid hemorrhage from ruptured intracranial aneurysm.

Breast Neoplasms: Tumors or cancer of the human BREAST.

Research Excerpts

ExcerptRelevanceReference
"Among the 48 human ABC proteins, the breast cancer resistance protein (BCRP/ABCG2) has been described as a pivotal player in cancer resistance."2.82Targeting breast cancer resistance protein (BCRP/ABCG2): Functional inhibitors and expression modulators. ( Delabio, LC; Dutra, JP; Hembecker, M; Kita, DH; Moure, VR; Pereira, GDS; Scheiffer, G; Valdameri, G; Zattoni, IF, 2022)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Zattoni, IF1
Delabio, LC1
Dutra, JP1
Kita, DH1
Scheiffer, G1
Hembecker, M1
Pereira, GDS1
Moure, VR1
Valdameri, G1
Al-Taweel, N1
Varghese, E1
Florea, AM1
Büsselberg, D1
Filos, KS1
Goudas, LC1
Patroni, O1
Tassoudis, V1

Reviews

1 review available for nimodipine and Breast Neoplasms

ArticleYear
Targeting breast cancer resistance protein (BCRP/ABCG2): Functional inhibitors and expression modulators.
    European journal of medicinal chemistry, 2022, Jul-05, Volume: 237

    Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; Breast Neoplasms; Dr

2022

Trials

1 trial available for nimodipine and Breast Neoplasms

ArticleYear
Analgesia with epidural nimodipine.
    Lancet (London, England), 1993, Oct-23, Volume: 342, Issue:8878

    Topics: Adult; Aged; Analgesia; Analgesia, Epidural; Breast Neoplasms; Female; Humans; Injections, Intraveno

1993

Other Studies

1 other study available for nimodipine and Breast Neoplasms

ArticleYear
Cisplatin (CDDP) triggers cell death of MCF-7 cells following disruption of intracellular calcium ([Ca(2+)]i) homeostasis.
    The Journal of toxicological sciences, 2014, Volume: 39, Issue:5

    Topics: Antineoplastic Agents; Breast Neoplasms; Calcium; Calcium Channel Blockers; Calcium Signaling; Cell

2014